GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Delivra Health Brands Inc (FRA:U01) » Definitions » 3-Year Revenue Growth Rate

Delivra Health Brands (FRA:U01) 3-Year Revenue Growth Rate : 7.10% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Delivra Health Brands 3-Year Revenue Growth Rate?

Delivra Health Brands's Revenue per Share for the three months ended in Sep. 2024 was €0.01.

During the past 12 months, Delivra Health Brands's average Revenue per Share Growth Rate was -20.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Delivra Health Brands was 230.20% per year. The lowest was -1.00% per year. And the median was 7.10% per year.


Competitive Comparison of Delivra Health Brands's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's 3-Year Revenue Growth Rate falls into.



Delivra Health Brands 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Delivra Health Brands  (FRA:U01) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Delivra Health Brands 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Delivra Health Brands's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Delivra Health Brands Business Description

Traded in Other Exchanges
Address
999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.

Delivra Health Brands Headlines

No Headlines